Bioequivalence Study of Spironolactone Tablets in Healthy Subjects
Status:
COMPLETED
Trial end date:
2023-08-23
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to Evaluate the Bioequivalence of Spironolactone Tablets 100mg (by SPH Sine Pharmaceutical Laboratories Co.,Ltd) and ALDACTONE® tablets 100mg (by GD SEARLE LLC) in Chinese Healthy Adult Volunteers under Fasting and Fed Conditions. It will also learn about the safety of the two drugs.